10. Cooper Sa. High Prevalence Of Dementia Amongst People With Learning Disabilities Not Attributed To Down Syndrome. Psychol Medic 1997; 27: 609-616.
11. Dennis J. Psychological And Behavioral Phenotypes In Genetically Determined Syndromes: A Review Of Research Findings: Down Syndrome. En: O’brien G, Yule W, Eds. Behavioral Phenotypes. London: Mac Keith Press. 1995 P. 105-109.
12. Devenny Da, Silverman Wp, Hill Al, Jenkins E, Sersen Ea, Wisniewski Kw, Envejecimiento Normal En Adultos Con Síndrome De Down: Un Estudio Longitudinal. Rev Síndrome Down 1997; 14: 94-104.
13. Devenny, D.A.Et Al (1992) Ageing In Higher Functioning Adults With Down’s Syndrome: An Interim Report In A Longitudinal Study. Journal Of Intelectualdisability Research,Vohxmen 36, 241-250.
14. Down Jl. Observation On An Ethnic Classification Of Idiots. London Hospital. Clinical Lectures And Reports 1866; 3: 259-262.
15. Eisering, JJ (1987). Aspectos Del Envejecimiento En El Síndrome De Down Sigh Cero, 113,42-48.
16. Epstein Cj, Korenberg J, Anneren G, Et Al. Protocols To Establish Genotype-Phenotype Correlations In Down Syndrome. Am J Hum Genet 1991; 49: 207-235.
17. Evenhuis Hm. Evaluation Of A Screening Instrument For Dementia In Aging Mentally. Retarded Persons. J Intellect Disabil Res 1992; 36: 337-347.
18. Evenhuis Hm. Medical Aspects Of Ageing In A Population With Intellectual Disability: Iii. Mobility, Internal Conditions And Cancer. J Intel Disabil Res 1997; 41: 8-18.
19. Evenhuis Hm. The Natural History Of Dementia In Ageing People With Intellectual Disability. J Intel Disabil Res 1997; 41: 92-96.
20. Evenhuis Hm. The Natural History Of Dementia In Down’s Syndrome. Arch Neurol 1990; 47: 263-267.
21. Eyman, R Et Al (1991) Life Expectancy Of Persons With Down Syndrome. American Journal On Mental Retardation, Vol 95, N.o 6, 603-12.
22. Florez J. Aspectos Médicos Del Anciano Con Deficiencia Mental. En: Gafo J (Ed). Deficiencia Mental Y Problemas Éticos En Torno Al Final De La Vida Madrid, Pub. Univ. Pontificia Comillas 2000.
23. Florez J. Envejecimiento Y Síndrome De Down. ¿Alzheimer, Si O No? Rev Síndrome Down 1993; 10: 55-62.
24. Florez J. Nuevos Tratamientos. Rev Síndrome Down 1999; 16: 49-51.
25. Florez J. Terapéutica Farmacológica De Las Demencias. Medicine 1998; 7(99): 4633-4643.
26. Florez, J (1993) El Envejecimiento De Las Personas Con Síndrome De Down: ¿Alzheimer, Si O No? Revista Síndrome De Down Cantabria. Set. 55-62.
27. Gedye A. Dementia Scale For Down Syndrome. P.O. Box 39081. Point Grey, Vancouver.
28. Gibson Et Al (1988) Age And Pattern Of Intelectual Decline Among Down’s Syndrome And Other Mentally Retarded. International Journal Of Rehabilitation Research, Vol 11, 47-55.
29. Hofman A, Rocca Wa, Brayne C, Et Al. The Prevalence Of Dementia In Europe: A Collaborative Study Of 1989-90 Findings. Int Jepidemiol 1991; 20: 736-748.
30. Hyman Bt, West Hl, Rebeck Gw, Buldyrev Sv, Mantegna Rn, Ukleja M, Havlin S, Stanley He. Quantitative Analysis Of Sennile Plaques In Alzheimer Disease: Observation Of Log-Normal Size Distribution And Molecular Epidemiology Of Differences Associated With Apolipoprotein E Genotype And Trisomy 21 (Down Syndrome). Proc Natl Acad Sci 1995; 92: 3586-3590.
31. Janicki, M (1987). Perspectiva General Del Envejecimiento Y La Deficiencia Mental. Siis-Real Patronato De Pre. Y Atención A Personas Con Minusvalía. Colección Documentos, Pag. 37.
32. Jervis Ga. Early Senile Dementia In Mongoloid Idiocy. Am J Psychiatry 1948; 105: 102-106.
33. Johannsen P, Christensen Je, Mai J. The Prevalence Of Dementia In Down Syndrome. Dementia 1996; 7: 221-225.
34. Kishnani Ps, Sullivan Ja, Walter Bk, Spiridigliozzi Ga, Doraiswamy Pm, Krishnan Krr. Cholinergic Therapy For Down’s Syndrome. Lancet 1999; 353: 1063-1065.
35. Korenberg J, Kawashima H, Pulst S, Et Al. Molecular Definition Of A Region Of Chromosome 21 That Causes Features Of The Down Syndrome Phenotype. J Hum Genet 1990; 47: 236-246.
36. Korenberg Jr, Chen Xn, Schipper R, Et Al. Down Syndrome Phenotypes: The Consequences Of Chromosomal Imbalance. Proc Natl Acad Sci Usa 1994; 91: 4997-5001.
37. Korenberg Jr. Down Syndrome Phenotypic Mapping. En: Epstein Cj, Ed. Morphogenesis And Down Syndrome. New York: Wiley-Liss 1991.
38. Lai F, Williams Rs. A Prospective Study Of Alzheimer Disease In Down Syndrome. Arch Neurol 1989; 46: 849-853.
39. Lejeune J, Gautier M, Turpin R. Etudes Des Chromosomes Somatiques De Neuf Enfants Mongoliens. Comptes Rendues Hebdomadaires Des Seances De L’academie Des Sciences. Paris. 1959; 248: 602-603.
40. Lemere Ca, Blusztajn Jk, Yamaguchi H, Visniewski T, Saido Tc, Selkow Dj. Sequence Of Deposition Of Heterogeneous Amyloid Beta-Peptides And Apo E In Down Syndrome: Implications For Initial Events In Amyloid Plaque Formation. Neurobiol Dis 1996; 3: 16-32.
41. Mann Dma. Alzheimer’s Disease And Down’s Syndrome. Histopathology 1988; 13: 125-137.
42. Martín Carrasco Manvel. La enfermedad de Alzheimer un trastorno neuropsiquiátrico. Ars Médica 2004 p. 161-184.
43. Mazur-Kolecka B, Kowal D, Sukontasup T, Dickson D, Frackowiak 3. The Effect Of Oxidative Stress On Accumulation Of Apolipoprotein E3 And E4 In A Cell Culture Model Of 8-Amyloid Angiopathy (Caa). Brain Res 2003; 983: 48-57.
44. Mcguire De, Chicoine Ba. Trastornos Depresivos En Los Adultos Con Síndrome De Down. Rev Síndrome Down 1997; 14: 11-16.
45. Mcnamara Mj, Gómez-Isla T, Hyman Bt. Apolipoprotein E Genotype And Deposits Of Abeta40 And Abeta42 In Alzheimer Disease. Arch Neurol 1998; 55: 1001-1004.
46. Patterson, D. The Integrated Map Of Human Chromosome 21. Prog Clin Biol Res 1995.
47. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Et Al. Apolipoprotein E, Dementia And Cortical Deposition Of Beta-Amyloid Protein. N Eng J Med 1995; 333: 1242-1247.
48. Prasher Vp, Chowdhury Ta, Rowe Br, Bain Sc. Apoe Genotype And Alzheimer’s Disease In Adults With Down Syndrome: Meta-Analysis. Am J Ment Retard 1997; 102: 103-110.
49. Prasher Vp, Chung Mc, Haque Ms. Longitudinal Changes In Adaptive Behavior In Adults With Down Syndrome: Interim Findings From A Longitudinal Study. Am J Ment Retard 1998; 103: 40-46.
50. Prasher Vp, Chung Mc. Causes Of Age-Related Decline In Adaptive Behavior Of Adults With Down Syndrome: Differential Diagnoses Of Dementia. Am J Merit Retard 1996; 101: 175-183.
51. Prasher Vp, Farrer Mj, Kessling Am, Et Al. Molecular Mapping Of Alzheimer-Type Dementia In Down’s Syndrome. Ann Neurol 1998; 43: 380-383.
52. Prasher Vp, Filer A. Behavioural Disturbance In People With Down’s Syndrome And Dementia. J Intellect Disabil Res 1995; 39: 432-436.
53. Prasher Vp. Dementia Questionnaire For Persons With Mental Retardation (Dmr): Modified Criteria For Adults With Down Syndrome. Jappl Res Intellect Disabil 1997; 10: 54-60.
54. Prasher Vp. End-Stage Dementia In Adults With Down Syndrome. Int J Geriat Psychiat 1995; 10:1067-1069.
55. Prasher, V.P. Et Al (1993) Age Of Onset And Duration Of Dementia In People With Down Syndromerintegration Of 98 Reported Cases In The Literature. Internationaljournal Of Geriatric Psychiatry, Vol 8: 915-22
56. Ribes R. El Procés D’envelliment En La Persona Amb La Síndrome De Down. Indicadors Del Procés De Deteriorament Cognitiu I Funcional Relacionats Amb La Demència Alzheimer. Tesis Doctoral, Universidad De Lérida 1999.
57. Schupf N, Kapell D, Lee Jh, Zigman W, Canto B, Tycko B, Mayeux R. Onset Of Dementia Is Associated With Apolipoprotefna E Epsilon 4 In Down’s Syndrome. Ann Neurol 1996; 40: 799-801.
58. Schupf N, Patel B, Silverman W, Zigman Wb, Zhong N, Tycko B, Mehta Pd, Mayeux R. Elevated Plasma Amyloid B-Peptide 1-42 And Onset Of Dementia On Adults With Down Syndrome. Neurosci Let 2001; 301: 199-203.
59. Strauss D, Zigman Wb. Behavioral Capabilities And Mortality Risk In Adults With And Without Down Syndrome. Am J Ment Retard 1996; 101: 269-281
60. Teller Jk, Russo C, Debusk Lm, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann Dm, Yabaton M, Gambetti P. Presence Of Soluble Amyloid Beta Peptide Precedes Amyloid Plaque Formation In Down’s Syndrome. Nat Med 1996; 2: 93-95.
61. Van Dyke Dc, Harper Dc, Dyken E. Alzheimer’s Disease And Down Syndrome. Down Syndrome Quart 1998; 3 (No. 3): 1-11.
62. Vicari S, Carlesimo A, Caltagirone C. Short Term Memory In Persons With Intellectual Disabilities And Down Syndrome. J Intellect Disabil Res 199.5; 39: 532-537.
63. Vicari S, Caselli Mc, Tonucci F. Asynchrony Of Lexical And Morphosyntactic Development In Children With Down Syndrome. Neuropsychol 2000; 38: 634-644.
64. Visser Fe, Aldenkamp Ap, Van Huffelen Ac, Kuilman M, Overweg J, Van Wijk J. Early Signs Of Dementia Checklist. Am J Ment Retard 1997; 101: 400-412.
65. Visser Fe, Kuilman M, Oosting J, Overweg J, Van Wijk J, Van Huffelen Ac. Use Of Electroencephalography To Detect Alzheimer’s Disease In Down’s Syndrome. Acta Neurol Scand 1996; 94: 97-103.
66. Williams Ca, Doms Rw, Lee Vm. Intracellular App Processing And A Beta Production In Alzheimer Disease. Jneuropathol Exp Neurol 1999; 58: 787-794.
67. Wilson Ca, Doms Rw, Lee Vm. Intracellular App Processing And Abeta Production In Alzheimer Disease. Jneuropathol Exp Neurol 1999; 58: 787-794.
68. Zigman Wb, Schupf N, Sersen E, Et Al. Prevalence Of Dementia In Adults With And Without Down Syndrome. Am Jment Retard 1996; 100: 403-412.
69. Zigman Wb, Schupf N, Sersen E, Silverman W. Prevalence Of Dementia In Adults With And Without Down Syndrome. Am J Ment Retard 1995; 100: 403-412.
70. Zigman Wb, Schupf N, Zigman A, Silverman W. Aging And Alzheimer Disease In People With Mental Retardation. En: Bray Nw (Ed), International Review Of Research In Mental Retardation (Vol. 19). New York, Academic Press 1993; P. 41-70.
71. Zigman, W Et Al (1987). Premature Regression Of Adults With Down’s Syndrome American Journal Of Mental Deficiency.V.92 N2 161-68.
72. Zitmanova I, Koritar P. Markers of oxidative stress in children with Down syndrome. Clin Chem Lab Med, 2006; 44 (3): 306-10.
* Resumen del trabajo presentado para la obtención del título de Master en Psicogeriaría de la Universiad Autónoma de Barcelona, 7.a edición (2004-206).